MyAverix Finance
F · Healthcare
Genomic Vision Société Anonyme (G09)
Diagnostics & Research
Genomic Vision Société Anonyme (G09) is listed on F in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $693,190, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for G09
Genomic Vision Société Anonyme (G09) — FAQ
What is Genomic Vision Société Anonyme's market cap?
Genomic Vision Société Anonyme (G09) has a reported market cap of $693,190 (data as of 2026-03-29).
What is G09's P/E ratio?
The price-to-earnings (P/E) ratio for Genomic Vision Société Anonyme (G09) is 18.00 (data as of 2026-03-29).
Does Genomic Vision Société Anonyme pay a dividend?
Dividend yield is not available in the current snapshot for Genomic Vision Société Anonyme (G09). Check the MyAverix Finance app for the latest dividend data.
What sector is Genomic Vision Société Anonyme in?
Genomic Vision Société Anonyme (G09) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is G09 listed on?
G09 is listed on F.
What is Genomic Vision Société Anonyme's net margin?
Genomic Vision Société Anonyme (G09) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.